ANXA2 and breast carcinoma: Researches have shown that exosomal ANXA2 derived from breast cancer cells can not only promote angiogenesis in a tissue plasminogen activator (tPA) ‐dependent manner but also activate multiple signalling pathways and regulate the secretion of factors in macrophages.40